The nurse working in a radiation oncology department is interested in improving patient outcomes for those with skin breakdown who receive beam radiation
Which of the following is the best way to structure a clinical question to guide a literature search?
a. What nursing interventions minimize the occurrence of skin breakdown in patients receiving beam radiation?
b. How often do patients with beam radiation experience skin breakdown?
c. Why do patients who get radiation beam therapy have skin breakdown?
d. How does our rate of skin breakdown in patients receiving beam radiation compare to other institutions in the city?
ANS: A
Asking a burning clinical question is the first step in the evidence-based practice (EBP) process. It is important to include related factors in the question and to focus on nursing interventions and care. For this scenario, the nurse would focus on nursing care that may reduce the occurrence of skin breakdown for the specific patient population of interest.
You might also like to view...
The adult dose of a drug is 10 mL. The dose for a child whose BSA is 0.58 m2 is _______________
a. 5.8 mL b. 3.4 mL c. 3.9 mL d. 9.9 mL
A client tells the nurse, "My healthcare provider told me that I have COPD and might develop emphysema. I always thought I had chronic bronchitis." Which response should the nurse provide the client?Note: Credit will be given only if all correct choices and no incorrect choices are selected. Select all that apply.
A. "Are you certain you do not have asthma?" B. "Chronic bronchitis has no relation to COPD." C. "COPD is either asthma, chronic bronchitis, or emphysema, or a combination of those disorders." D. "As COPD progresses, it becomes emphysema." E. "Both diagnoses are correct."
________ is the only steroid approved for nonprescription products.
A. Hydrocortisone B. Budesonide C. Fluticasone D. Dexamethasone
A disease in which the principal manifestation is an abnormal growth of cells leading to formation of tumors is called a __________ disease
A. congenital B. degenerative C. metabolic D. neoplastic